REPLIMUNE GROUP INC 76029N106 09/03/2025 To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers for the fiscal year ended March 31, 2025. SECTION 14A SAY-ON-PAY VOTES 233386 0 FOR 233386 FOR ARROWHEAD PHARMACEUTICALS, INC. 04280A100 03/19/2026 Advisory Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES 32237 0 FOR 32237 FOR BIOHAVEN LTD G1110E107 04/28/2026 A non-binding advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 123896 0 FOR 123896 FOR BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 36374 0 FOR 36374 FOR INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 5101 0 FOR 5101 FOR ELI LILLY AND COMPANY 532457108 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 5559 0 FOR 5559 FOR PENUMBRA, INC. 70975L107 05/06/2026 To approve, on a non-binding, advisory basis, the compensation that Penumbra's named executive officers will or may be eligible to receive in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES 6300 0 FOR 6300 FOR INSMED INCORPORATED 457669307 05/13/2026 An advisory vote on the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 16128 0 FOR 16128 FOR VERA THERAPEUTICS, INC. 92337R101 05/21/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 85072 0 FOR 85072 FOR VERASTEM, INC. 92337C203 05/21/2026 To approve an advisory vote on the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES 549212 0 FOR 549212 FOR ESTABLISHMENT LABS HOLDINGS INC. G31249108 05/22/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 13100 0 FOR 13100 FOR ARBUTUS BIOPHARMA CORPORATION 03879J100 05/26/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular. SECTION 14A SAY-ON-PAY VOTES 50166 0 FOR 50166 FOR CYTOKINETICS, INCORPORATED 23282W605 05/27/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 81951 0 FOR 81951 FOR GLAUKOS CORPORATION 377322102 05/28/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 20874 0 FOR 20874 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 06/01/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES 12862 0 FOR 12862 FOR CRESCENT BIOPHARMA, INC. G2545C104 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of Crescent Biopharma, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES 153191 0 FOR 153191 FOR 10X GENOMICS, INC. 88025U109 06/04/2026 A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 21 0 FOR 21 FOR IONIS PHARMACEUTICALS, INC. 462222100 06/04/2026 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES 84684 0 FOR 84684 FOR MOONLAKE IMMUNOTHERAPEUTICS 61559X104 06/04/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 166493 0 FOR 166493 FOR COGENT BIOSCIENCES, INC. 19240Q201 06/09/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 227855 0 FOR 227855 FOR ENLIVEN THERAPEUTICS, INC. 29337E102 06/09/2026 To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES 25437 0 FOR 25437 FOR ENLIVEN THERAPEUTICS, INC. 29337E102 06/09/2026 To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 150407 0 FOR 150407 FOR RELAY THERAPEUTICS, INC. 75943R102 06/09/2026 To consider and act upon an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 218303 0 FOR 218303 FOR COMPASS THERAPEUTICS, INC. 20454B104 06/10/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 225098 0 FOR 225098 FOR PRAXIS PRECISION MEDICINES, INC. 74006W207 06/10/2026 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the compensation tables and narrative discussion. SECTION 14A SAY-ON-PAY VOTES 36405 0 FOR 36405 FOR NATERA, INC. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 3059 0 FOR 3059 FOR NATERA, INC. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 13800 0 FOR 13800 FOR LIQUIDIA CORPORATION 53635D202 06/16/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 35066 0 FOR 35066 FOR LIQUIDIA CORPORATION 53635D202 06/16/2026 to approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 6902 0 FOR 6902 FOR 4D MOLECULAR THERAPEUTICS, INC. 35104E100 06/17/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote"). SECTION 14A SAY-ON-PAY VOTES 130564 0 FOR 130564 FOR CYTOMX THERAPEUTICS, INC. 23284F105 06/17/2026 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. SECTION 14A SAY-ON-PAY VOTES 469978 0 FOR 469978 FOR GUARDANT HEALTH, INC. 40131M109 06/17/2026 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 70395 0 FOR 70395 FOR AGIOS PHARMACEUTICALS, INC. 00847X104 06/18/2026 To vote, on an advisory basis, to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 139659 0 FOR 139659 FOR PENUMBRA, INC. 70975L107 06/18/2026 To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 6300 0 FOR 6300 FOR RHYTHM PHARMACEUTICALS, INC. 76243J105 06/24/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES 32209 0 FOR 32209 FOR UNITED THERAPEUTICS CORPORATION 91307C102 06/26/2026 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES 5091 0 FOR 5091 FOR